A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation capacity in order to meet the demand for one of their client’s recently approved therapeutic. This need for additional capital and operational expenditures resulted from a sudden increase in campaign volumes that subsequently increased the demand for process liquids and buffers.